Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Heart Failure Drugs: Diuretics

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...

Transducer Mechanism: Enzyme-Linked Receptors

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...

Antihypertensive Drugs: Potassium-Sparing Diuretics

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...

Hormonal Regulation of Blood Pressure

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...

Heart Failure II: Pathophysiology

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

C-Type Natriuretic Peptide and Cardiovascular-Renal Protection in Sepsis.

Hypertension (Dallas, Tex. : 1979)·2026

Same author

The Concise Guide to PHARMACOLOGY 2025/26: Catalytic receptors.

British journal of pharmacology·2025

Same author

Effects of physiological doses of atrial natriuretic peptide on lipolysis, ketogenesis, and glucose metabolism in men.

American journal of physiology. Endocrinology and metabolism·2025

Same author

C-Type Natriuretic Peptide: Protecting the Aorta.

Arteriosclerosis, thrombosis, and vascular biology·2025

Same author

Significance of common genetic variants associated with non-ischaemic cardiomyopathy in the general population.

European journal of heart failure·2025

Same author

NPA7: A Dual Receptor Activating Peptide That Inhibits Cardiac Oxidative Stress.

Hypertension (Dallas, Tex. : 1979)·2025

Same journal

EXPRESS: Association between composite lipid indices (AIP, VAI, LAP) and Carotid Atherosclerosis with plaque: a Systematic review and Meta-analysis.

Journal of investigative medicine : the official publication of the American Federation for Clinical Research·2026

Same journal

Meta-analysis of the clinical efficacy of microcatheter-assisted trabeculotomy in the treatment of glaucoma.

Journal of investigative medicine : the official publication of the American Federation for Clinical Research·2026

Same journal

EXPRESS: The Association of Hidradenitis Suppurativa with Increased Risk of Systemic Infections in End-stage Renal Disease.

Journal of investigative medicine : the official publication of the American Federation for Clinical Research·2026

Same journal

Artificial intelligence perceptions and experiences among first and second year medical students.

Journal of investigative medicine : the official publication of the American Federation for Clinical Research·2026

Same journal

Effects of the glucagon-like peptide-1 and glucagon receptor dual agonists on glycemic markers: A systematic review and meta-analysis of randomized controlled trials.

Journal of investigative medicine : the official publication of the American Federation for Clinical Research·2026

Same journal

EXPRESS: Enhancing clinical core competencies in postgraduate medical education: a comparative study of augmented reality-assisted and traditional teaching approaches.

Journal of investigative medicine : the official publication of the American Federation for Clinical Research·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 26, 2026

Isolation of Atrial Myocytes from Adult Mice

Isolation of Atrial Myocytes from Adult Mice

Published on: July 25, 2019

Designer natriuretic peptides.

Candace Y W Lee¹, Hsiao Lieu, John C Burnett

¹Departments of Internal Medicine and Physiology, Division of Cardiovascular Disease, Cardiorenal Research Laboratory, Mayo Clinic College of Medicine, Rochester, MN 55906, USA.

Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research

|January 23, 2009

Summary

This summary is machine-generated.

Designer natriuretic peptides (NPs) are engineered molecules offering optimized pharmacological actions. This review covers lab-designed NPs and discusses future research for these novel therapeutic agents.

More Related Videos

Nitropeptide Profiling and Identification Illustrated by Angiotensin II

Nitropeptide Profiling and Identification Illustrated by Angiotensin II

Published on: June 16, 2019

Cardiac Loading using Passive Left Atrial Pressurization and Passive Afterload for Graft Assessment

Cardiac Loading using Passive Left Atrial Pressurization and Passive Afterload for Graft Assessment

Published on: August 2, 2024

Related Experiment Videos

Last Updated: Jun 26, 2026

Isolation of Atrial Myocytes from Adult Mice

Isolation of Atrial Myocytes from Adult Mice

Published on: July 25, 2019

Nitropeptide Profiling and Identification Illustrated by Angiotensin II

Nitropeptide Profiling and Identification Illustrated by Angiotensin II

Published on: June 16, 2019

Cardiac Loading using Passive Left Atrial Pressurization and Passive Afterload for Graft Assessment

Cardiac Loading using Passive Left Atrial Pressurization and Passive Afterload for Graft Assessment

Published on: August 2, 2024

Area of Science:

Biochemistry
Pharmacology
Peptide Engineering

Background:

Native natriuretic peptides (NPs) possess crucial physiological roles.
Native NPs have limitations for therapeutic applications.
Engineering NPs aims to enhance efficacy and reduce side effects.

Purpose of the Study:

To review designer natriuretic peptides (NPs) developed in our laboratory.
To discuss the design principles and optimization strategies for NPs.
To outline future directions in designer NP research and development.

Main Methods:

Engineering of native NPs through amino acid addition, deletion, or substitution.
Pharmacological evaluation of designed peptide sequences.
Review of selected laboratory-developed designer NPs.

Main Results:

Designer NPs demonstrate optimized pharmacological profiles compared to native counterparts.
Specific examples of engineered NPs with improved characteristics are presented.
The potential for designer NPs in various therapeutic areas is highlighted.

Conclusions:

Designer NPs represent a promising class of therapeutic agents.
Further research and development are warranted to fully realize their clinical potential.
Amino acid modifications offer a powerful tool for NP optimization.